DE69926061D1 - Verfahren und zusammensetzungen zur peptidsynthese (t-20) - Google Patents

Verfahren und zusammensetzungen zur peptidsynthese (t-20)

Info

Publication number
DE69926061D1
DE69926061D1 DE69926061T DE69926061T DE69926061D1 DE 69926061 D1 DE69926061 D1 DE 69926061D1 DE 69926061 T DE69926061 T DE 69926061T DE 69926061 T DE69926061 T DE 69926061T DE 69926061 D1 DE69926061 D1 DE 69926061D1
Authority
DE
Germany
Prior art keywords
peptides
present
peptide
synthesis
interest
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69926061T
Other languages
English (en)
Other versions
DE69926061T2 (de
Inventor
Myung-Chol Kang
Brian Bray
Maynard Lichty
Catherine Mader
Gene Merutka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Trimeris Inc
Original Assignee
Trimeris Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/045,920 external-priority patent/US6281331B1/en
Application filed by Trimeris Inc filed Critical Trimeris Inc
Application granted granted Critical
Publication of DE69926061D1 publication Critical patent/DE69926061D1/de
Publication of DE69926061T2 publication Critical patent/DE69926061T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69926061T 1998-03-23 1999-03-22 Verfahren und zusammensetzungen zur peptidsynthese (t-20) Expired - Lifetime DE69926061T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US45920 1998-03-23
US09/045,920 US6281331B1 (en) 1998-03-23 1998-03-23 Methods and compositions for peptide synthesis
US71877 1998-05-01
US09/071,877 US6015881A (en) 1998-03-23 1998-05-01 Methods and compositions for peptide synthesis
PCT/US1999/006230 WO1999048513A1 (en) 1998-03-23 1999-03-22 Methods and compositions for peptide synthesis

Publications (2)

Publication Number Publication Date
DE69926061D1 true DE69926061D1 (de) 2005-08-11
DE69926061T2 DE69926061T2 (de) 2006-06-01

Family

ID=26723345

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69926061T Expired - Lifetime DE69926061T2 (de) 1998-03-23 1999-03-22 Verfahren und zusammensetzungen zur peptidsynthese (t-20)

Country Status (13)

Country Link
EP (1) EP1071442B9 (de)
JP (1) JP4602547B2 (de)
CN (1) CN100383158C (de)
AT (1) ATE299029T1 (de)
AU (1) AU751358B2 (de)
BR (1) BR9909018A (de)
CA (1) CA2324348C (de)
DE (1) DE69926061T2 (de)
DK (1) DK1071442T3 (de)
ES (1) ES2245505T3 (de)
NZ (1) NZ507083A (de)
TW (1) TWI233931B (de)
WO (1) WO1999048513A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6281331B1 (en) * 1998-03-23 2001-08-28 Trimeris, Inc. Methods and compositions for peptide synthesis
US6469136B1 (en) * 1999-07-07 2002-10-22 Trimeris, Inc. Methods and composition for peptide synthesis
ES2525317T3 (es) 2001-06-15 2014-12-22 F. Hoffmann-La Roche Ag Producción recombinante de inhibidores de la fusión antivirales peptídicos
WO2004013164A1 (en) * 2002-07-24 2004-02-12 F. Hoffmann-La Roche Ag Pegylated t20 polypeptide
ATE410437T1 (de) 2003-12-31 2008-10-15 Hoffmann La Roche Verfahren und systeme zur rückgewinnung von peptiden
ES2295961T3 (es) 2003-12-31 2008-04-16 F. Hoffmann-La Roche Ag Proceso para la sintesis peptidica utilizacndo una cantidad reducida de agente de desproteccion.
WO2005063799A2 (en) * 2003-12-31 2005-07-14 F.Hoffmann-La Roche Ag Peptide synthesis and deprotection with co-solvent
EP1833843B1 (de) * 2004-12-30 2009-10-14 F. Hoffmann-La Roche Ag Synthese des peptides t-20 aus peptidfragmenten als zwischenprodukte
AU2007248855A1 (en) 2006-05-03 2007-11-15 Mallinckrodt Inc. Composition and method for the release of protected peptides from a resin
JP5515738B2 (ja) * 2007-07-25 2014-06-11 味の素株式会社 ジベンゾフルベン誘導体の淘汰方法
JP5473925B2 (ja) * 2007-10-27 2014-04-16 コーデン ファーマ コロラド インコーポレイテッド 固相および溶液相の組み合わせ技法を使用するインスリン分泌性ペプチドの合成
EP2222695A2 (de) * 2007-12-11 2010-09-01 F. Hoffmann-La Roche AG Synthese eines insulinotropen peptids mithilfe von feststoff- und flüssigphasenkombinationsverfahren
EP2322498B1 (de) * 2008-08-06 2014-04-16 Ajinomoto Co., Inc. Verfahren zur entfernung von dibenzofulven
US20110288235A1 (en) * 2008-09-03 2011-11-24 Scinopharm Taiwan Ltd. Process for the Preparation of Pramlintide
TWI395752B (zh) * 2008-09-03 2013-05-11 Scinopharm Taiwan Ltd 製造比伐蘆汀（ｂｉｖａｌｉｒｕｄｉｎ）之方法
WO2011095989A2 (en) * 2010-02-04 2011-08-11 Matrix Laboratories Ltd An improved process for the preparation of enfuvirtide
PL219569B1 (pl) * 2010-02-19 2015-05-29 Peptaderm Spółka Z Ograniczoną Odpowiedzialnością Cykliczne tetrapeptydy i ich zastosowanie
CN103374054B (zh) * 2012-04-28 2014-12-24 上海第一生化药业有限公司 一步法固相合成多肽的方法
GB201315335D0 (en) 2013-08-29 2013-10-09 Of Singapore Amino diacids containing peptide modifiers
BR112022015055A2 (pt) 2020-02-05 2022-09-20 Lilly Co Eli Três reatores de resina em série para sintetizador de peptídeo
CN114315957B (zh) * 2021-12-30 2023-07-07 深圳瑞德林生物技术有限公司 一种多肽的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU617088B2 (en) * 1986-06-12 1991-11-21 Biogen, Inc. Peptides involved in the pathogenesis of hiv infection
US4787222A (en) * 1986-11-24 1988-11-29 Novatek Medical Inc. Combination lock for blood identification system
US5444044A (en) * 1992-03-26 1995-08-22 New York Blood Center Synthetic polypeptides as inhibitors of HIV-1
US6479055B1 (en) * 1993-06-07 2002-11-12 Trimeris, Inc. Methods for inhibition of membrane fusion-associated events, including respiratory syncytial virus transmission
US5864027A (en) * 1993-06-07 1999-01-26 Genentech, Inc. HIV envelope polypeptides
US5464933A (en) * 1993-06-07 1995-11-07 Duke University Synthetic peptide inhibitors of HIV transmission
WO1995007354A1 (en) * 1993-09-11 1995-03-16 Polymun Scientific Immunobiologische Forschung Gmbh Peptides that elicit neutralizing antibodies against genetically divergent hiv-1 strains
KR100493795B1 (ko) * 1996-02-09 2005-09-09 에프. 호프만-라 로슈 아게 혈관활성장펩타이드유사체의합성방법

Also Published As

Publication number Publication date
TWI233931B (en) 2005-06-11
CN100383158C (zh) 2008-04-23
EP1071442B1 (de) 2005-07-06
CA2324348C (en) 2006-03-14
AU751358B2 (en) 2002-08-15
CN1303299A (zh) 2001-07-11
NZ507083A (en) 2003-10-31
JP4602547B2 (ja) 2010-12-22
DE69926061T2 (de) 2006-06-01
BR9909018A (pt) 2001-10-16
EP1071442A1 (de) 2001-01-31
EP1071442A4 (de) 2002-06-05
WO1999048513A1 (en) 1999-09-30
ES2245505T3 (es) 2006-01-01
JP2002507576A (ja) 2002-03-12
DK1071442T3 (da) 2005-10-24
AU3109799A (en) 1999-10-18
EP1071442B9 (de) 2006-01-18
ATE299029T1 (de) 2005-07-15
CA2324348A1 (en) 1999-09-30

Similar Documents

Publication Publication Date Title
DE69926061D1 (de) Verfahren und zusammensetzungen zur peptidsynthese (t-20)
BRPI9909018B8 (pt) processo para a síntese de um peptídeo
WO2001034635A3 (en) Methods and compositions for peptide synthesis
Butler Dentin matrix proteins
DE69935085D1 (de) Verfahren und Zusammensetzung zur Hemmung des neoplastischen Zellwachstums
ATE357518T1 (de) Verfahren und zusammensetzungen zur inhibierung des neoplastischen zellwachstums
UA40621C2 (uk) Моноклональне антитіло, гібридомна клітинна лінія, поліпептид (варіанти), фрагмент днк (варіанти), фармацевтична композиція, спосіб одержання моноклонального антитіла
MX348154B (es) Anticuerpos de enlace a il-1-beta y fragmentos de los mismos.
BG103522A (en) Compositions and methods for ob type protein syntheses
DK0813545T3 (da) Nukleotid- og proteinsekvenser af hvirveldyrs-Serrate-gener og fremgangsmåde baseret derpå
ATE290014T1 (de) Festphasen-peptidsynthese
DK0861261T3 (da) Nukleotid- og proteinsekvenser af hvirveldyrs-Delta-gener og fremgangsmåder baseret derpå
CA2102208A1 (en) Binding domains in notch and delta proteins
DZ3482A1 (fr) Secretagogues de l'hormone de croissance
WO2004113493A3 (en) Compositions and methods for enhanced expression of immunoglobulins from a single vector using a peptide cleavage site
Young et al. The amino acid sequences of jacalin and the Maclura pomifera agglutinin
ATE394482T1 (de) Verfahren und zusammensetzungen für peptid-, protein- und peptidomimetische synthese
JPS58116443A (ja) 新規ペプチドおよびその製法
George et al. The phosphophoryn gene family: identical domain structures at the carboxyl end
DE60310958D1 (de) Synthese und charakterisierung neuer systeme zum hinführen und zur vektorisierung von molekülen von therapeutischem interesse zu targetzellen
MXPA02012378A (es) Secuencias de nucleotidos y aminoacidos de factores de oocito para alterar el crecimiento folicular ovarico in vivo in vitro.
WO1999063094A3 (en) Nucleotide and protein sequences of gpr1 and methods based thereon
Ekkati et al. Preparation of N-acetyl, tert-butyl amide derivatives of the 20 natural amino acids
WO2007022251A3 (en) Prostatic acid phosphatase and prostate cancer
ATE235509T1 (de) Peptide zur inhibition von hpv e7 proteinen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition